With the county experiencing the second-highest growth rate in Indiana, builders and apartment developers have not been able to meet the increasing demand for affordable and workforce housing.
Gantenerumab’s demise is a boost for Indianapolis-based Eli Lilly and Biogen, which are also developing treatments for Alzheimer’s, said Tim Anderson, an analyst at Wolfe Research. Lilly shares were up 1.8% at midday.
Twitter’s relaunched premium service—which grants blue-check “verification” labels to anyone willing to pay $8 a month—was unavailable Friday after the social media platform was flooded by a wave of impostor accounts.
Purdue University has rehired Dan Hasler to coordinate the school’s expansion in Indianapolis following an August decision to split IUPUI into separate Indiana University and Purdue operations.
Ultimately, no part of the state should become economically parched due to the lack of an adequate water supply. And care must be taken to make sure existing aquifers aren’t overtaxed or abused.
In a significant expansion of their longstanding collaboration, the partners hope to develop new models for delivering therapies to patients and provide full tuition to between 75 and 100 students each year for 10 years.
The Lebanon City Council on Monday night approved an agreement that would reserve water and wastewater for a $2.1 billion Eli Lilly and Co. development in Boone County.
The IU School of Medicine announced won a five-year, $48.8 million grant from the National Institute on Aging, a division of the National Institutes of Health, to create in mice genetic mutations similar to those found in people with late-onset Alzheimer’s.
To meet the water demands of an innovation district planned for just north of Lebanon, state officials are exploring the idea of tapping into the Wabash aquifer in Tippecanoe County.
The Indianapolis-based drugmaker said it has reached a definitive agreement to acquire Akouos Inc., a seven-year-old biotech firm, which is running early clinical trials for its lead therapy for hearing loss.
The lawsuit was filed this month by a senior sales representative who worked for Eli Lilly for 11 years before resigning in June. The complaint seeks class-action status on behalf of thousand of employees and former employees of Lilly.
When the dollar is strong, a U.S.-based company that sells products overseas earns fewer dollars. On the flip side, the cost of imported goods and foreign expenses are lower.
Indianapolis-based Eli Lilly and Co. announced Thursday that it has received a Fast Track designation from the U.S. Food and Drug Administration to investigate its diabetes drug tirzepatide for the treatment of adults with obesity.
The money will be used to study animal models of late-onset Alzheimer’s disease as well as perform rigorous testing of potential therapeutics in animals.
Michele Sawyer started Sept. 1 as chief financial officer at the Indiana Biosciences Research Institute after more than two decades at drugmaker Eli Lilly and Co. and its animal health spinoff, Elanco Animal Health.
